Spotlight on inhaled ciprofloxacin and its potential in the treatment of non-cystic fibrosis bronchiectasis
Stamatia Chorepsima,1,2 Konstantinos S Kechagias,1 Georgios Kalimeris,1,2 Nikolaos A Triarides,1,2 Matthew E Falagas1–3 1Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece; 2Department of Medicine, Henry Dunant Hospital Center, Athens, Greece; 3Department of Medicine, Tufts Univ...
Main Authors: | Chorepsima S, Kechagias KS, Kalimeris G, Triarides NA, Falagas ME |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-11-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/spotlight-on-inhaled-ciprofloxacin-and-its-potential-in-the-treatment--peer-reviewed-article-DDDT |
Similar Items
-
Development of Inhalable Nanostructured Lipid Carriers for Ciprofloxacin for Noncystic Fibrosis Bronchiectasis Treatment
by: Almurshedi AS, et al.
Published: (2021-03-01) -
Delafloxacin––A novel fluoroquinolone for the treatment of ciprofloxacin‐resistant Pseudomonas aeruginosa in patients with cystic fibrosis
by: Beverley Cherie Millar, et al.
Published: (2021-01-01) -
Comparison of respiratory pathogen colonization and antimicrobial susceptibility in people with cystic fibrosis bronchiectasis versus non-cystic fibrosis bronchiectasis: a protocol for a systematic review
by: Salony Verma, et al.
Published: (2021-01-01) -
Ciprofloxacin, an antibiotic with cardiac actions on isolated rat hearts
by: Loipa Galán-Martínez, et al.
Published: (2018-04-01) -
Comparing infective complications from transrectal ultrasound guided prostate biopsy following transition to single dose oral ciprofloxacin prophylaxis
by: Matthew Farag, et al.
Published: (2019-01-01)